Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial.
Jarvis, Joseph N
; Chou, Roger; Harrison, Thomas S; Lawrence, David S; Muthoga, Charles; Mupeli, Kennedy; Meya, David B; Mwandumba, Henry C; Kanyama, Cecilia; Meintjes, Graeme; +7 more...Leeme, Tshepo B; Ndhlovu, Chiratidzo E; Beattie, Pauline; Sued, Omar; Pérez Casas, Carmen; Makanga, Michael; and Ford, Nathan
(2023)
Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial.
The Lancet Global health, 11 (11).
e1688-e1690.
ISSN 2214-109X
DOI: 10.1016/S2214-109X(23)00412-6
; Chou, Roger; Harrison, Thomas S; Lawrence, David S; Muthoga, Charles; Mupeli, Kennedy; Meya, David B; Mwandumba, Henry C; Kanyama, Cecilia; Meintjes, Graeme; +7 more...Leeme, Tshepo B; Ndhlovu, Chiratidzo E; Beattie, Pauline; Sued, Omar; Pérez Casas, Carmen; Makanga, Michael; and Ford, Nathan
(2023)
Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial.
The Lancet Global health, 11 (11).
e1688-e1690.
ISSN 2214-109X
DOI: 10.1016/S2214-109X(23)00412-6
Translating evidence from clinical trials to routine care can take many years, particularly in low-income and middle-income countries, delaying access to lifesaving or life-changing treatments. As few as one in five evidence-based health interventions are incorporated into routine use, and the average time lag between evidence availability and practice change is up to 17 years.
-
picture_as_pdf - Jarvis-etal-2023-Translating-evidence-into-global-impact.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads